The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kuchina A.Yu.

Sechenov First Moscow State Medical University, Ministry of Health of the Russia, Moscow, Russia

Novikova N.A.

Pervyĭ MGMU im. I.M. Sechenova, klinika kardiologii

Suvorov A.Yu.

Sechenov First Moscow State Medical University, Ministry of Health of the Russia, Moscow, Russia

Shidlovskaya S.A.

Department of Preventive and Emergency Cardiology of I.M. Sechenov First Moscow State Medical University, Moscow, Russia

Arshinova I.A.

Sechenov First Moscow State Medical University, Ministry of Health of the Russia, Moscow, Russia

Characteristics of advanced age patients with atrial fibrillation in clinical practice (in Russian only)

Authors:

Kuchina A.Yu., Novikova N.A., Suvorov A.Yu., Shidlovskaya S.A., Arshinova I.A.

More about the authors

Read: 2146 times


To cite this article:

Kuchina AYu, Novikova NA, Suvorov AYu, Shidlovskaya SA, Arshinova IA. Characteristics of advanced age patients with atrial fibrillation in clinical practice (in Russian only). Russian Journal of Cardiology and Cardiovascular Surgery. 2019;12(3):213‑221. (In Russ., In Engl.)
https://doi.org/10.17116/kardio201912031213

Recommended articles:
Effi­ciency of complex medi­cal reha­bilitation after pulmonary enda­rterectomy. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):629-636
Stroke: current state of the problem. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):7-18
Fibrin mono­mer in diagnosis of cardiovascular diseases. Russian Cardiology Bulletin. 2024;(4-2):113-120

References:

  1. Kistler P, Sanders P, Fynn S, et al. Electrophysiologic and electroanatomic changes in the human atrium associated with age. J Am Coll Cardiol. 2004;44:109-116.
  2. Amin A, Houmsse A, Ishola A., et al. The current approach of atrial fibrillation management. Avicenna J Med. 2016;6(1):8-16.
  3. Kilickap M, Bosch J, Eikelboom JW, Hart RG. Antithrombotic treatments for stroke prevention in elderly patients with non- valvular atrial fibrillation: Drugs and doses. Can J Cardiol. 2016;32(9):1108-1116.
  4. Bassand JP, et al. Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF. Eur Heart J. 2016;37(38):2882-2889.
  5. Shlyahto EV, Ezhov AV, Zenin SA, Koziolova NA, Korennova OYu, Novikova TN, Protasov KV, Sumin MN, Chumakova GA, Lip GY, Huisman MV, Rothman KJ. Clinical portrait of a patient with atrial fibrillation in the Russian Federation. The global register Gloria AF. Russian Journal of Cardiology. 2017;9(149):21-27. (In Russ.) doi: 10.15829/1560-4071-2017-9-21-27
  6. Nabauer M, Gerth A, Limbourg T, et.al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace. 2009;11:423-434.
  7. Camm AJ, Breithardt G, Crijns H. Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J Am Coll Cardiol. 2011 Jul 26;58(5):493-501.
  8. Alam M, Bandeali SJ, Shahzad SA. Real-life global survey evaluating patients with atrial fibrillation (REALISE-AF): results of an international observational registry. Expert Rev Cardiovasc Ther. 2012 Mar;10(3):283-291.
  9. Martsevich SYu, Ginzburg ML, Kutishenko NP, et al. The LIS research (Study of mortality among patients survived acute myocardial infarction in Lyubertsy district): a portrait of a diseased. Cardiovascular therapy and prevention. 2011;10(6):89-93. (In Russ.)
  10. Boytsov SA, Martsevich SYu, Ginzburg ML. Lyubertsy study of mortality rate in patients with previous stroke or transient ischemic attack (LIS-2). Design and medical treatment estimation. Ration Pharmacother Cardiol. 2013;9(2):114-122. (In Russ.)
  11. Lip GYH, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Petrescu L, Darabantiu D, Crijns HJGM, Kirchhof P, Vardas P, Tavazzi L, Maggioni AP, Borani G. Prognosis and treatment of atrial fibrillation patients by European cardiologists: One Year Follow-up of the EURO observational Research Programme Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot Registry). Eur Heart J. 2014;35:3365-3376.
  12. Olesen JB, Lip GY, Kamper AL, et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med. 2012; 367(7):625-635.
  13. Lukyanov MM, Boytsov SA, Yakushin SS, Martsevich S, Vorobev AN, Zagrebelny AV, Harlap MS, Pereverzeva KG, Pravkina EA, Serdyuk SE, Deev AD, Kudryashov E.N. Diagnosis, treatment, concomitant cardiovascular pathology and comorbidities in patients with atrial fibrillation in real practice (according to the register of Cardiovascular Diseases REKVAZA). Rational Pharmacotherapy in Cardiology. 2014;10(4):366-377. (In Russ.)
  14. Sulimov VA, Golitsin VP, Panchenko EP, et al. Diagnosis and treatment of atrial fibrillation. Recommendations RKO, VNOA, ASS. Moscow. 2013;14. (In Russ.)
  15. Revishvili ASh, Rzayev FG, Gorev MV, Nardaya ShG, et al. Clinical recommendations «Diagnosis and treatment of atrial fibrillation». Recommendations RKO, VNOA, ASS. Moscow, 2017. (In Russ.) http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/population/
  16. Hakim FA, Shen WK. Atrial fibrillation in the elderly: a review. Future Cardiol. 2014;10(6):745-758.
  17. Providencia R, Marijon E, Boveda S, et al. Metaanalysis of the influence of chronic kidney disease on the risk of thromboembolism among patients with nonvalvular atrial fibrillation. Am J Cardiol. 2014;114(4):646-653.
  18. Piccini JP, Stevens SR, Chang Y, et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation. 2013;127(2):224-232.
  19. Olesen JB, Lip GY, Kamper AL, et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med. 2012;367(7):625-635.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.